Atlas Trials

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Clinical trial NCT06355310 · RECRUITING

Trial details

NCT number
NCT06355310
Sponsor
Justin Ryder
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Fatty Liver Disease
Start date
2025-04-10
Primary completion
2028-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.